SEQUESSOME TECHNOLOGY

WIPO WIPO 2011

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke SEQUESSOME TECHNOLOGY wurde als Wortmarke am 20.12.2011 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 22. Dezember 2021

Markenform Wortmarke
Aktenzeichen 1121803A
Länder Moldawien
Anmeldedatum 20. Dezember 2011
Ablaufdatum 20. Dezember 2031

Markeninhaber

10A, 4th Floor,
premises 39 (office 451.1),
RU

Markenvertreter

Bedford House, John Street GB

Waren und Dienstleistungen

05 Pharmaceutical preparations and substances; veterinary and sanitary preparations and substances; chemical preparations for pharmaceutical purposes; pharmaceuticals in the field of osteoarthritis, oncology, cardiovascular disease, respiratory disease, inflammation, infection, gastrointestinal diseases and central nervous system diseases; diagnostic preparations for medical and veterinary use; topical and parenteral preparations of vesicles; chemical preparations in the form of vesicles for medical and veterinary purposes; chemical membranes and chemical aggregates for medical and veterinary purposes; preparations of arachidonic acids; dispersions and dry preparations of liposomal active substance carriers for pharmaceutical, cosmetic and veterinary substances; cosmeceutical preparations for medical use; anti-inflammatory drugs; lipids for topical and parenteral use; creams, dispersions, lotions, ointments, gels, solutions, sprays, lacquers and film forming solution for the treatment of pain or inflammation; surfactants for use in the treatment of or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders, the treatment of inflammation, asthma, atopic eczema, dishydrotic hand eczema, plaque type psoriasis, seborrheic eczema, acne vulgaris, bronchospasm, atherothrombotic cardiovascular disorders, venous thrombotic disorders, pain, dysmenorrhea, hypercholesterolemia, hypertriglyceridemia, fatty acid metabolism, metal or other toxicity, alzheimer's disease, gout or macular degeneration, such as AMD, or fungal infection, and disorders related to fatty acid deficiencies
10 Medical devices for topical use in allowing subcutaneous absorption for the treatment of pain; molecular filtering devices for medical use; medical, veterinary and surgical apparatus, instruments and devices; apparatus, instruments and devices for dispensing medical, surgical and veterinary preparations, dispersions, creams, powders, tablets and pills; instruments and devices for the administration of therapy and prophylaxis preparations and substances; parts and fittings for all of the aforesaid
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
20. Dezember 2021 2021/51 Gaz Verlängerung
04. Juli 2013 2013/28 Gaz MD Ablehnung

ID: 999914112180365